Mathematical modeling of HIV-1 transmission risk from condomless anal intercourse in HIV-infected MSM by the type of initial ART
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mathematical modeling of HIV-1 transmission risk from condomless anal intercourse in HIV-infected MSM by the type of initial ART
Authors
Keywords
HIV-1, Men who have sex with men, Antiretroviral therapy, Sexually transmitted diseases, Viral load, Comparators, HIV, HIV epidemiology
Journal
PLoS One
Volume 14, Issue 7, Pages e0219802
Publisher
Public Library of Science (PLoS)
Online
2019-07-20
DOI
10.1371/journal.pone.0219802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
- (2018) Benjamin R Bavinton et al. Lancet HIV
- Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
- (2016) Alison J. Rodger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
- (2016) Sheena McCormack et al. LANCET
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission
- (2016) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
- (2015) AJ Rodger et al. HIV MEDICINE
- On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
- (2015) Jean-Michel Molina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimating per-act HIV transmission risk
- (2014) Pragna Patel et al. AIDS
- Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
- (2014) Bonaventura Clotet et al. LANCET
- The increase in global HIV epidemics in MSM
- (2013) Chris Beyrer et al. AIDS
- Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
- (2013) François Raffi et al. LANCET INFECTIOUS DISEASES
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global epidemiology of HIV infection in men who have sex with men
- (2012) Chris Beyrer et al. LANCET
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relation between HIV viral load and infectiousness: a model-based analysis
- (2008) David P Wilson et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation